Company intelligence / Profile preview

Sebela Pharmaceuticals

Roswell, Georgia, United Statessebelapharma.com ↗

Ownership: Private
Employees: ~206
Development stage: Phase 3

Overview

Sebela Pharmaceuticals is a U.S.-based company with a strong focus on Gastroenterology and Women's Health. It has developed and commercialized several products, including SUFLAVE, SUTAB, and SUPREP BOWEL PREP KIT for gastrointestinal applications, and MIUDELLA, a hormone-free IUD for contraception.

Therapeutic areas: GastroenterologyWomen's Health
Modalities: Small moleculesintrauterine devices (IUDs)
Industry: Biotech

Drug pipeline

7 assets

miudella

Approved

6 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Sebela Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sebela Pharmaceuticals.

Explore the full profile